All patients underwent a standard, three-port 23-G pars plana vitrectomy with ERM peeling performed by one vitreoretinal surgeon (MYL) with the Constellation vision system (Alcon, Fort Worth, TX). Combined phacoemulsification and intraocular lens implantation procedures were performed in phakic eyes. Core vitrectomy was performed with the creation of posterior vitreous detachment. Then, ERM removal up to the vascular arcades was done using Grieshaber internal limiting membrane forceps (Alcon). At the end of the surgery, partial air–fluid exchange was performed in all cases.
Diluted vitreous (approximately 1.0 mL) samples were collected at the onset of pars plana vitrectomy and were immediately frozen at −80°C until use. The vitreous samples were analyzed using a multiplex bead assay system (Luminex, R&D Systems, Minneapolis, Minnesota, USA). Using this system, the concentrations of cytokines in each vitreous sample were detected and quantified in parallel, as follows: monocyte chemoattractant protein-1 (CCL2), MIP-1beta (CCL4), CD163, GRO alpha (CXCL1), IP-10 (CXCL10), stromal cell-derived factor-1 alpha (CXCL12), IL-8 (CXCL8), granulocyte-macrophage colony-stimulating factor, IFN-gamma, IL-17A, IL-18, IL-2, IL-4, CD163, macrophage colony-stimulating factor (M-CSF), MMP-9, Periostin, and VEGF. All procedures were performed according to the manufacturer's guidelines by experienced laboratory technicians who were blinded to the study details.